In last month’s newsletter, the Life Raft Group published its study on the effects of imatinib dose upon the survival of metastatic GIST patients. On February 4, we also held a webcast, “The Link Between Dosage and Survival”. Since then we have had a number of questions about the study. Some of the questions had […]
The Latest News from the Life Raft Group